Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 442

Results For "STI"

7023 News Found

Cepheid launches its first manufacturing unit in India
News | March 15, 2023

Cepheid launches its first manufacturing unit in India

The facility has been set up to manufacture tuberculosis testing cartridges


Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP
Drug Approval | March 15, 2023

Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP

Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million


RTsafe announces first use of its PseudoPatient patient-specific quality assurance process
News | March 15, 2023

RTsafe announces first use of its PseudoPatient patient-specific quality assurance process

Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment


Philips and Gibraltar Health Authority announce 16-year strategic partnership
News | March 15, 2023

Philips and Gibraltar Health Authority announce 16-year strategic partnership

Patients will no longer need to travel abroad for treatment of acute cardiac diseases


LifeSigns raises Pre-Series A
News | March 15, 2023

LifeSigns raises Pre-Series A

A funding to expand operations and provide better patient care


Pfizer acquires Seagen for US$ 43 billion to battle cancer
News | March 14, 2023

Pfizer acquires Seagen for US$ 43 billion to battle cancer

Proposed combination enhances Pfizer’s position as a leading company in oncology


Dr. Lal PathLabs selects Kyndryl for cloud services management
Digitisation | March 14, 2023

Dr. Lal PathLabs selects Kyndryl for cloud services management

Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces


Alpla and Inden pharma form joint venture
News | March 14, 2023

Alpla and Inden pharma form joint venture

ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma


Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division
Drug Approval | March 13, 2023

Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division

The company will be submitting the responses to US FDA observations within stipulated timeline


Agilent announces digital pathology workflow solution
Digitisation | March 13, 2023

Agilent announces digital pathology workflow solution

Open, scalable, end-to-end solution to improve diagnostic quality and efficiency